The Food and Drug Administration (FDA) of USA has given approval to Dr Reddy's to sell its Nabumetone. The official website of the FDA says that, drug name NABUMETONE of Generic Drug group with application no. (ANDA) 078420 is given approval on the date September 24, 2008. Evidently, the FDA is one of the USA's oldest and most respected consumer protection agencies.

 

The FDA tries to promote and protect the public health by helping safe and effective products reach the market in a timely way. Also, it monitors products for continued safety after they are in use, and helps the public get the accurate, science-based information needed to improve health. With the approval from FDA, Nabumetone, the tablets which are non-steroidal anti-inflammatory drugs will be used for the treatment of arthritis related pain.

 

Dr. Reddy’s on the other hand, founded by Dr K Anji Reddy in the year 1984 has more than 190 medications ready for patients to take. By the end of the year 2007, Dr. Reddy’s had six FDA-plants producing active pharmaceutical ingredients in India. Also, it has seven FDA-inspected certified plants making patient-ready medications. The firm specializes in drug manufacturing, diagnostic kits, critical care and biotechnology products.